AAAAAA
Results: 1-25/56
Authors:
STRANGE PG
Citation: Pg. Strange, 3-STATE AND 2-STATE MODELS, Trends in pharmacological sciences, 19(3), 1998, pp. 85-86
Authors:
TAMIMI NA
STEVENS PE
ODONNELL PL
STRANGE PG
MUCHANETAKUBARA EC
ELNAHAS AM
Citation: Na. Tamimi et al., EXPRESSION OF CYTOSKELETAL PROTEINS DIFFERENTIATES BETWEEN PROGRESSORS AND NONPROGRESSORS IN TREATED IDIOPATHIC MEMBRANES NEPHROPATHY, Experimental nephrology, 6(3), 1998, pp. 217-225
Authors:
MCCANN FE
TREHERNE JM
STRANGE PG
BAINES AJ
Citation: Fe. Mccann et al., NEUROTROPHIC EFFECTS OF FK506 ON DOPAMINERGIC-NEURONS IN MESENCEPHALIC SLICE CULTURES, European journal of neuroscience, 10, 1998, pp. 6910-6910
Authors:
WELSH GI
HALL DA
WARNES A
STRANGE PG
PROUD CG
Citation: Gi. Welsh et al., ACTIVATION OF MICROTUBULE-ASSOCIATED PROTEIN-KINASE (ERK) AND P70 S6 KINASE BY D-2 DOPAMINE-RECEPTORS, Journal of neurochemistry, 70(5), 1998, pp. 2139-2146
Authors:
GARDNER B
STRANGE PG
Citation: B. Gardner et Pg. Strange, AGONIST ACTION AT D-2(LONG) DOPAMINE-RECEPTORS - LIGAND-BINDING AND FUNCTIONAL ASSAYS, British Journal of Pharmacology, 124(5), 1998, pp. 978-984
Authors:
PRESLAND J
STRANGE PG
Citation: J. Presland et Pg. Strange, PHARMACOLOGICAL CHARACTERIZATION OF THE D2 DOPAMINE RECEPTOR-EXPRESSED IN THE YEAST SCHIZOSACCHAROMYCES-POMBE, Biochemical pharmacology, 56(5), 1998, pp. 577-582
Authors:
STRANGE PG
Citation: Pg. Strange, ATYPICAL NEUROLEPTICS HAVE LOW-AFFINITY FOR DOPAMINE D-2 RECEPTORS ORARE SELECTIVE FOR D-4 RECEPTORS - COMMENTARY, Neuropsychopharmacology, 16(2), 1997, pp. 116-122
Authors:
SARTANIA N
STRANGE PG
Citation: N. Sartania et Pg. Strange, STRUCTURE-FUNCTION-RELATIONSHIPS AT HUMAN D-3 DOPAMINE-RECEPTOR, The FASEB journal, 11(9), 1997, pp. 363-363
Authors:
VILE JM
STRANGE PG
Citation: Jm. Vile et Pg. Strange, ATYPICAL ANTIPSYCHOTICS - SEROTONERGIC MECHANISMS BUT DONT FORGET DOPAMINE, J PSYCHOPH, 11(1), 1997, pp. 24-25
Authors:
TAMIMI NA
ODONNELL PJ
MUCHANETAKUBARA EC
STRANGE PG
ELNAHAS AM
Citation: Na. Tamimi et al., RENAL MYOFIBROBLASTS PREDICT RESPONSE TO TREATMENT IN MEMBRANOUS NEPHROPATHY, Kidney international, 52(1), 1997, pp. 278-279
Authors:
GARDNER BR
HALL DA
STRANGE PG
Citation: Br. Gardner et al., AGONIST ACTION AT D-2(SHORT) DOPAMINE-RECEPTORS DETERMINED IN LIGAND-BINDING AND FUNCTIONAL ASSAYS, Journal of neurochemistry, 69(6), 1997, pp. 2589-2598
Authors:
HALL DA
STRANGE PG
Citation: Da. Hall et Pg. Strange, EVIDENCE THAT ANTIPSYCHOTIC-DRUGS ARE INVERSE AGONISTS AT D-2 DOPAMINE-RECEPTORS, British Journal of Pharmacology, 121(4), 1997, pp. 731-736
Authors:
COLEY C
WOODWARD R
STRANGE PG
NAYLOR LH
Citation: C. Coley et al., ANTAGONIST BINDING TO THE D-2 DOPAMINE-RECEPTOR AND THE ROLE OF CONSERVED SERINE RESIDUES, British Journal of Pharmacology, 120, 1997, pp. 276-276
Authors:
CORDEAUX Y
STRANGE PG
Citation: Y. Cordeaux et Pg. Strange, SODIUM SENSITIVITY OF SUBSTITUTED BENZAMIDE BINDING AT D-2 DOPAMINE-RECEPTORS EXPRESSED IN CHO AND SF21 CELLS, British Journal of Pharmacology, 120, 1997, pp. 277-277
Authors:
MCLOUGHLIN DJ
STRANGE PG
Citation: Dj. Mcloughlin et Pg. Strange, FUNCTIONAL-CHARACTERIZATION OF AGONISTS AT SEROTONIN 5-HT1A RECEPTORS, British Journal of Pharmacology, 120, 1997, pp. 296-296
Authors:
STRANGE PG
Citation: Pg. Strange, THE ENERGETICS OF LIGAND-BINDING AT CATECHOLAMINE RECEPTORS, Trends in pharmacological sciences, 17(7), 1996, pp. 238-244
Authors:
STRANGE PG
Citation: Pg. Strange, 7TM RECEPTORS - LOCKS AND KEYS, Trends in pharmacological sciences, 17(10), 1996, pp. 346-346
Authors:
HOARE SRJ
COLDWELL MC
STRANGE PG
Citation: Srj. Hoare et al., ALLOSTERIC REGULATION OF RAT AND HUMAN DOPAMINE-RECEPTOR SUBTYPES - EVIDENCE FOR 2 BINDING STATES FOR [H-3] SPIPERONE, Biochemical Society transactions, 24(1), 1996, pp. 53-53
Authors:
STRANGE PG
Citation: Pg. Strange, THE BINDING OF AGONISTS AND ANTAGONISTS TO DOPAMINE-RECEPTORS, Biochemical Society transactions, 24(1), 1996, pp. 188-192
Authors:
HOARE SRJ
STRANGE PG
Citation: Srj. Hoare et Pg. Strange, REGULATION OF D-2 DOPAMINE-RECEPTORS BY AMILORIDE AND AMILORIDE ANALOGS, Molecular pharmacology, 50(5), 1996, pp. 1295-1308
Authors:
WOODWARD R
COLEY C
DANIELL S
NAYLOR LH
STRANGE PG
Citation: R. Woodward et al., INVESTIGATION OF THE ROLE OF CONSERVED SERINE RESIDUES IN THE LONG FORM OF THE RAT D-2 DOPAMINE-RECEPTOR USING SITE-DIRECTED MUTAGENESIS, Journal of neurochemistry, 66(1), 1996, pp. 394-402
Authors:
HALL DA
STRANGE PG
Citation: Da. Hall et Pg. Strange, NEUROLEPTIC DRUGS BEHAVE AS INVERSE AGONISTS AT THE SHORT ISOFORM OF THE HUMAN D-2 DOPAMINE-RECEPTOR HETEROLOGOUSLY EXPRESSED IN CHO CELLS, British Journal of Pharmacology, 119, 1996, pp. 268-268
Authors:
GARDNER B
HALL DA
STRANGE PG
Citation: B. Gardner et al., PHARMACOLOGICAL ANALYSIS OF DOPAMINE STIMULATION OF [S-35] GTP-GAMMA-S BINDING VIA HUMAN D-2SHORT AND D-2LONG DOPAMINE-RECEPTORS EXPRESSED IN RECOMBINANT CELLS, British Journal of Pharmacology, 118(6), 1996, pp. 1544-1550
Authors:
GARDNER BR
STRANGE PG
Citation: Br. Gardner et Pg. Strange, ON THE QUANTIFICATION OF RECEPTOR FUNCTION AND THE MOLECULAR MECHANISMS OF AGONIST ACTION AT G-PROTEIN LINKED RECEPTORS, British Journal of Pharmacology, 117, 1996, pp. 1-1
Authors:
HALL DA
STRANGE PG
Citation: Da. Hall et Pg. Strange, INVERSE AGONISM OF THE NEUROLEPTIC DRUG (-BUTACLAMOL AT THE SHORT ISOFORM OF THE HUMAN D-2-DOPAMINE RECEPTOR HETEROLOGOUSLY EXPRESSED IN CHO CELLS()), British Journal of Pharmacology, 117, 1996, pp. 282-282